Participating Companies and Organizations
IASP wishes to thank and acknowledge its supporters and exhibitors for their generous support of the IASP 2021 Virtual World Congress on Pain.
GlaxoSmithKline Consumer HealthcareSymposium Organizer
GSK is a science-led global company with a special purpose: to help people do more, feel better, live longer. Our Consumer Healthcare business develops and markets an innovative portfolio of globally recognised consumer-preferred and expert-recommended brands. Our vision for the Pain Relief portfolio is to free More and More People from Pain Everyday.
Pain Medicine NewsCongress Supporter and Exhibitor
Pain Medicine News, the most widely read pain publication in the United States according to Kantar Media, is mailed to 41,554 pain-treating physicians and to 41,158 pain-treating nurse practitioners and physician assistants. It offers extensive coverage of major scientific meetings affecting the specialty, feature articles on topics relevant to practicing provider, in-depth clinical reviews, practice management articles, medical education, as well as a full line of digital media, including the PainMedicineNews.com website, e-Newsletters, and multimedia content.
Tilray is a global leader in medicinal cannabis research, cultivation, processing, and distribution. As proud pioneer, we are the first GMP-certified medicinal cannabis producer to supply cannabis flower and extract to tens of thousands of patients. We are committed to scientific research to advance the clinical applications of cannabinoids and improve patient quality of life.
Anatomic Incorporated provides scalable human stem cell derived nociceptors that express voltage gated sodium channels (NaV1.7, NaV1.8 and NaV1.9), calcium channels (CaV2.2), transient receptor potential vanilloid subtype 1 (TRPV1), and Piezo2 useful for high throughput pain drug discovery.
2001 6th Street SE #2-214, Minneapolis, MN 55455 USA
Helixmith is a gene therapy company developing new and innovative biopharmaceuticals targeting previously untreated diseases. VM202, the most advanced pipeline candidate, is a plasmid DNA therapy that is currently being studied in six different indications including in a currently enrolling phase 3 trial for painful diabetic peripheral neuropathy.
Established in 1993, Desert Harvest provides high-quality nutritional supplements and skincare products. In our study with McGill University Research Centre we are doing transitional pain research with our patented Cannabidiol/Aloe Vera combination in which experiments are performed on live pain-sensing neurons and spinal cords freshly obtained from human donors and plan to preview these results at IASP.
Alan Edwards Centre for Research on Pain (McGill University)Exhibitor
The AECRP brings together basic and clinical researchers from McGill University to promote research that will result in cures for chronic pain. Education and clinical translation are of particular interest. Stop by and see what the McGill Online Graduate Certificate in Chronic Pain Management is all about!
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers, students, and the next generation of healthcare providers. As a leader in medical publishing, we are the proud publisher of PAIN, the official journal of the International Association for the Study of Pain (IASP)